sanofi pasteur — The vaccines business of sanofi-aventis Group
Learn
VaccinePlace.com -- Search.  Know more.
Explore Protect Learn
Follow this link to www.daptacel.com    About Us  |  For Professionals  |  Tell a Friend

 
   
   
   
 
   
   
   
   
   
 
   
   
DAPTACEL Packaging

Image of DAPTACEL Vaccine Packaging




 
This site provided as a service by sanofi pasteur
 
Indication
 
DAPTACEL vaccine is given to infants and children 6 weeks through 6 years of age (prior to 7th birthday) to prevent three serious diseases: diphtheria, tetanus (lockjaw), and pertussis (whooping cough) as a five-dose series.
 
Safety Information
 
Side effects to DAPTACEL vaccine include injection site redness, swelling, and tenderness; fever, fussiness, drowsiness, and crying more than usual. Other side effects may occur. DAPTACEL vaccine should not be given to children who, after a previous dose of the vaccine, have had a serious allergic reaction (anaphylactic reaction) or inflammation of the brain (encephalopathy) not attributable to another cause. Tell the doctor if your child has ever experienced a severe brain disorder, such as encephalopathy (altered consciousness) or Guillain-Barré syndrome (severe muscle weakness), after a previous dose of a tetanus toxoid- or pertussis-containing vaccine. Vaccination with DAPTACEL vaccine may not protect all individuals.
 
For more information about DAPTACEL vaccine, talk to your health-care professional.
 

Last modified: 2/20/09
Provided as a service by Sanofi Pasteur Inc.
Copyright © 2010 Sanofi Pasteur Inc.
This page last updated: 11-Aug-2010